Author:
Sun Di,Ding Min,Ruan Mengfan,Yang Li,Qi Xingshun
Abstract
Hepatitis C virus (HCV), an oncogenic virus, is a well-known risk factor for hepatocellular carcinoma. Some studies have shown an increased risk of extrahepatic tumors in HCV patients, but the risk of different types of extrahepatic tumors remains controversial. Early prevention of extrahepatic tumors in HCV patients should be further explored. Therefore, this chapter aims to explore the association between HCV infection and extrahepatic tumors.
Reference62 articles.
1. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nature Reviews. Cancer. 2010;(12):878-889. DOI: 10.1038/nrc2961
2. Gulli F, Marino M, Napodano C, Pocino K, Pandolfi F, Gasbarrini A, et al. Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma. European Review for Medical and Pharmacological Sciences. 2020;(15):8067-8074. DOI: 10.26355/eurrev_202008_22490
3. Yue T, Zhang Q , Cai T, Xu M, Zhu H, Pourkarim MR, et al. Trends in the disease burden of HBV and HCV infection in China from 1990-2019. International Journal of Infectious Diseases. 2022;:476-485. DOI: 10.1016/j.ijid.2022.06.017
4. Westbrook RH, Dusheiko G. Natural history of hepatitis C. Journal of Hepatology. 2014;(Suppl. 1):S58-S68. DOI: 10.1016/j.jhep.2014.07.012
5. Fiorino S, Bacchi-Reggiani L, de Biase D, Fornelli A, Masetti M, Tura A, et al. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology. 2015;(45):12896-12953. DOI: 10.3748/wjg.v21.i45.12896
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献